K C K, Baral A
Ann Med Surg (Lond). 2023; 85(11):5761-5764.
PMID: 37915700
PMC: 10617930.
DOI: 10.1097/MS9.0000000000001339.
Sinkey R, Ogunsile F, Kanter J, Bean C, Greenberg M
Am J Obstet Gynecol. 2023; 230(2):B17-B40.
PMID: 37866731
PMC: 10961101.
DOI: 10.1016/j.ajog.2023.10.031.
Kolvenbach C, Shril S, Hildebrandt F
Nat Rev Nephrol. 2023; 19(11):709-720.
PMID: 37524861
DOI: 10.1038/s41581-023-00742-9.
Yamashita K, Morimoto S, Inoue Y, Hirata K, Kimura S, Seki Y
J Endocr Soc. 2022; 6(8):bvac085.
PMID: 35733831
PMC: 9206722.
DOI: 10.1210/jendso/bvac085.
Ma G, Chen Y, Wu W, Chang S, Chang T, Lin W
Diagnostics (Basel). 2019; 9(4).
PMID: 31718018
PMC: 6963964.
DOI: 10.3390/diagnostics9040185.
Prenatal hypocalvaria after prolonged intrauterine exposure to angiotensin II receptor antagonists.
Lallemant M, Prevost S, Nobili F, Riethmuller D, Ramanah R, Seronde M
J Renin Angiotensin Aldosterone Syst. 2018; 19(4):1470320318810940.
PMID: 30394825
PMC: 6243420.
DOI: 10.1177/1470320318810940.
Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations.
Bateman B, Patorno E, Desai R, Seely E, Mogun H, Dejene S
Obstet Gynecol. 2016; 129(1):174-184.
PMID: 27926639
PMC: 5177460.
DOI: 10.1097/AOG.0000000000001775.
Survival over 2 years of autosomal-recessive renal tubular dysgenesis.
Kim S, Kang H, Kim E, Choi J, Choi Y, Cheong H
Clin Kidney J. 2015; 5(1):56-8.
PMID: 26069751
PMC: 4400456.
DOI: 10.1093/ndtplus/sfr153.
The relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia.
Ueki N, Takeda S, Koya D, Kanasaki K
Int J Endocrinol. 2015; 2015:572713.
PMID: 26000015
PMC: 4426891.
DOI: 10.1155/2015/572713.
The extreme anterior domain is an essential craniofacial organizer acting through Kinin-Kallikrein signaling.
Jacox L, Sindelka R, Chen J, Rothman A, Dickinson A, Sive H
Cell Rep. 2014; 8(2):596-609.
PMID: 25043181
PMC: 4135435.
DOI: 10.1016/j.celrep.2014.06.026.
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Bushnell C, McCullough L, Awad I, Chireau M, Fedder W, Furie K
Stroke. 2014; 45(5):1545-88.
PMID: 24503673
PMC: 10152977.
DOI: 10.1161/01.str.0000442009.06663.48.
Renal tubular dysgenesis.
Gubler M
Pediatr Nephrol. 2013; 29(1):51-9.
PMID: 23636579
DOI: 10.1007/s00467-013-2480-1.
Abnormal skull findings in neural tube defects.
Imbruglia L, Cacciatore A, Carrara S, Recupero S, La Galia T, Pappalardo E
J Prenat Med. 2012; 3(3):44-7.
PMID: 22439044
PMC: 3279104.
Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE.
Nesterovitch A, Hogarth K, Adarichev V, Vinokour E, Schwartz D, Solway J
PLoS One. 2009; 4(12):e8282.
PMID: 20011602
PMC: 2788243.
DOI: 10.1371/journal.pone.0008282.
Neonate with occipital scalp defect.
Le B, Anthony L, Lopes M
Brain Pathol. 2008; 18(4):616-8.
PMID: 18782178
PMC: 8095510.
DOI: 10.1111/j.1750-3639.2008.00214.x.
Renovascular hypertension commencing during fetal life.
Hegde S, Wright C, Shenoy M, Moghal N, Coulthard M
Arch Dis Child Fetal Neonatal Ed. 2006; 92(4):F301-4.
PMID: 16990369
PMC: 2675436.
DOI: 10.1136/adc.2006.104919.
Effects of maternally administered drugs on the fetal and neonatal kidney.
Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U
Drug Saf. 2006; 29(5):397-419.
PMID: 16689556
DOI: 10.2165/00002018-200629050-00004.
Teratogenicity with angiotensin II receptor antagonists in pregnancy.
Boix E, Zapater P, Pico A, Moreno O
J Endocrinol Invest. 2006; 28(11):1029-31.
PMID: 16483184
DOI: 10.1007/BF03345344.
Renal tubular dysgenesis and neonatal hemochromatosis without pulmonary hypoplasia.
Morris S, Akima S, Dahlstrom J, Ellwood D, Kent A, Falk M
Pediatr Nephrol. 2003; 19(3):341-4.
PMID: 14677054
DOI: 10.1007/s00467-003-1319-6.
Drug-induced congenital defects: strategies to reduce the incidence.
De Santis M, Carducci B, Cavaliere A, De Santis L, Straface G, Caruso A
Drug Saf. 2001; 24(12):889-901.
PMID: 11735646
DOI: 10.2165/00002018-200124120-00003.
